C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Many studies have examined histopathological factors and various prognostic scores related to inflammation to predict outcomes. Here, we examined the prognostic value of the C-reactive protein/albumin (CRP/alb) ratio in oral squamous cell carcinoma (OSCC).Materials and Methods: This retrospective study included 40 patients with OSCC. Using univariate and multivariate analyses, we focused on the correlation of the CRP/alb ratio with clinicopathological characteristics and with overall survival. We then compared five inflammation-based prog-nostic scores, CRP/alb ratio, modified Glasgow Prognostic Score (mGPS), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and prognostic nutritional index (PNI), based on receiver operating characteristic (ROC) curves.Results: The optimal cut-off value for the CRP/alb ratio was 0.085. The group with a high CRP/alb ratio had a high TNM clinical stage (P=0.002) and larger primary tumors (P=0.029), with statistically significant differences in lymph node metastasis and distant metastasis. In addition, when the CRP/alb ratio was high, multivariate analysis showed a lower survival rate (P=0.002; hazard ratio=6.078), and the ROC curve showed more outstanding dis-criminatory ability regarding overall survival compared to other inflammation-based prognostic scores.Conclusion: The CRP/alb ratio can be an independent prognostic factor when predicting prognosis in OSCC and has good prognostic ability.
Abstract
Objectives: Many studies have examined histopathological factors and various prognostic scores related to inflammation to predict outcomes. Here, we examined the prognostic value of the C-reactive protein/albumin (CRP/alb) ratio in oral squamous cell carcinoma (OSCC).Materials and Methods: This retrospective study included 40 patients with OSCC. Using univariate and multivariate analyses, we focused on the correlation of the CRP/alb ratio with clinicopathological characteristics and with overall survival. We then compared five inflammation-based prog-nostic scores, CRP/alb ratio, modified Glasgow Prognostic Score (mGPS), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and prognostic nutritional index (PNI), based on receiver operating characteristic (ROC) curves.Results: The optimal cut-off value for the CRP/alb ratio was 0.085. The group with a high CRP/alb ratio had a high TNM clinical stage (P=0.002) and larger primary tumors (P=0.029), with statistically significant differences in lymph node metastasis and distant metastasis. In addition, when the CRP/alb ratio was high, multivariate analysis showed a lower survival rate (P=0.002; hazard ratio=6.078), and the ROC curve showed more outstanding dis-criminatory ability regarding overall survival compared to other inflammation-based prognostic scores.Conclusion: The CRP/alb ratio can be an independent prognostic factor when predicting prognosis in OSCC and has good prognostic ability.
참고문헌 (46)
- Ju Rim Sun, "Oral cancer incidence based on annual cancer statistics in Korea", 대한구강악안면외과학회지, 38(1), pp.20~28 (2012), 대한구강악안면외과학회
- Lo Muzio L, "Oral squamous cell carcinoma and biological markers: an update on the molecules mainly involved in oral carcinogenesis", Minerva Stomatol, 56, pp.341~347 (2007)
- Spencer KR, "Current concepts in the management of oral squamous cell carcinoma", Aust Dent J, 47, pp.284~289 (2002)
- Klug C, "Preoperative chemoradiotherapy in the management of oral cancer: a review", J Craniomaxillofac Surg, 36, pp.75~88 (2008)
- Genden EM, "Contemporary management of cancer of the oral cavity", Eur Arch Otorhinolaryngol, 267, pp.1001~1017 (2010)
- 금동호, "The impact factors on 5-year survival rate in patients operated with oral cancer", 대한구강악안면외과학회지, 39(5), pp.207~216 (2013), 대한구강악안면외과학회
- Mantovani A, "Cancer-related inflammation", Nature, 454, pp.436~444 (2008)
- Sun K, "The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis", J Cancer Res Clin Oncol, 140, pp.1537~1549 (2014)
- Paramanathan A, "A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours", Surg Oncol, 23, pp.31~39 (2014)
- Gomez D, "Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma", World J Surg, 32, pp.1757~1762 (2008)
- Pinato DJ, "A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma:the prognostic nutritional index (PNI)", Br J Cancer, 106, pp.1439~1445 (2012)
- Liu H, "Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer", J Thorac Dis, 5, pp.783~789 (2013)
- Khandavilli SD, "Serum Creactive protein as a prognostic indicator in patients with oral squamous cell carcinoma", Oral Oncol, 45, pp.912~914 (2009)
- Jin Y, "Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer", Clinics (Sao Paulo), 68, pp.686~693 (2013)
- Liu X, "Preoperative C-reactive protein", albumin ratio predicts prognosis of patients after curative resection for gastric cancer, 2015, pp.8, 339~345
- Zhou T, "Ratio of Creactive protein", albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer, 2015, pp.5, 10481~
- Wei XL, "A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein", albumin ratio, 2015, pp.15, 350~
- Kinoshita A, "The C-reactive protein", albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma, 2015, pp.22, 803~810
- Edge SB, "The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
- Budczies J, "Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization", PLoS One, 7, pp.e51862~ (2012)
- Diakos CI, "Cancerrelated inflammation and treatment effectiveness", Lancet Oncol, 15, pp.e493~503 (2014)
- Hanahan D, "Hallmarks of cancer: the next generation", Cell, 144, pp.646~674 (2011)
- Balkwill F, "Inflammation and cancer: back to Virchow?", Lancet, 357, pp.539~545 (2001)
- Allavena P, "Chemokines in cancer related inflammation", Exp Cell Res, 317, pp.664~673 (2011)
- Castell JV, "Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6", Hepatology, 12, pp.1179~1186 (1990)
- Gallo O, "Interleukin-6 and acute-phase proteins in head and neck cancer", Eur Arch Otorhinolaryngol, 252, pp.159~162 (1995)
- Pepys MB, "C-reactive protein: a critical update", J Clin Invest, 111, pp.1805~1812 (2003)
- Coussens LM, "Inflammation and cancer", Nature, 420, pp.860~867 (2002)
- Nozoe T, "Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma", Am J Surg, 182, pp.197~201 (2001)
- Gockel I, "Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus", World J Gastroenterol, 12, pp.3746~3750 (2006)
- von Meyenfeldt M, "Cancer-associated malnutrition: an introduction", Eur J Oncol Nurs, 9(Suppl 2), pp.S35~38 (2005)
- Gupta D, "Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature", Nutr J, 9, pp.69~ (2010)
- Alberici Pastore C, "Association between an inflammatory-nutritional index and nutritional status in cancer patients", Nutr Hosp, 28, pp.188~193 (2013)
- Roxburgh CS, "Cancer and systemic inflammation:treat the tumour and treat the host", Br J Cancer, 110, pp.1409~1412 (2014)
- Metgud R, "Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy", Biotech Histochem, 89, pp.8~13 (2014)
- Rachidi S, "Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma", Head Neck, 38(Suppl 1), pp.E1068~1074 (2016)
- Farhan-Alanie OM, "Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma", Br J Oral Maxillofac Surg, 53, pp.126~131 (2015)
- Fang HY, "Refining the role of preoperative C-reactive protein by neutrophil", lymphocyte ratio in oral cavity squamous cell carcinoma, 2013, pp.123, 2690~2699
- Fairclough E, "Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein", albumin ratio as a predictor of patient outcome, 2009, pp.9, 30~33
- Ranzani OT, "Creactive protein", albumin ratio predicts 90-day mortality of septic patients, 2013, pp.8, e59321~
- Xu XL, "A novel inflammationbased prognostic score, the C-reactive protein", albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma, 2015, pp.10, e0138657~
- Proctor MJ, "Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study", Cancer, 119, pp.2325~2332 (2013)
- Proctor MJ, "An inflammation-based prognostic score (mGPS)predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study", Br J Cancer, 104, pp.726~734 (2011)
- Shafique K, "The modified Glasgow prognostic score in prostate cancer:results from a retrospective clinical series of 744 patients", BMC Cancer, 13, pp.292~ (2013)
- Zhou T, "A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer", Tumour Biol, 36, pp.337~343 (2015)
- McMillan DC, "The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer", Cancer Treat Rev, 39, pp.534~540 (2013)
